Table 4.

Clinical characteristics of the AKI cohort

Clinical CharacteristicsAKI, n=26
Bed location
 ICU21 (81%)
 General ward5 (19%)
Nephrotoxic medicationsa14 (54%)
Decreased left ventricular systolic function15 (58%)
Vasopressors18 (70%)
Mechanical ventilation1 (4%)
Dialysis1 (4%)
Treatment
 Steroids26 (100%)
 IVIG21 (81%)
 Anakinra5 (19%)
  • ICU, intensive care unit; IVIG, intravenous Ig.

  • a Nephrotoxic medications include aminoglycosides, trimethoprim/sulfamethoxazole, vancomycin, acyclovir, nonsteroidal anti-inflammatory drugs, iodine-based contrast for imaging, and calcineurin inhibitors.